Clinical Trials List
Protocol NumberR5458-ONC-2246
Not yet recruiting
2026-02-01 - 2034-11-14
Phase III
Not yet recruiting1
ICD-10C90.00
Multiple myeloma not having achieved remission
ICD-10C90.02
Multiple myeloma in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9203.00
Multiple myeloma, without mention of remission
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 王閔宏 Division of Hematology & Oncology
- 謝子禹 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- 許瑞峰 Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
915 participants
